Cardiovascular Development and Survival During Gestation in the Ts65Dn Mouse Model for Down Syndrome

被引:13
|
作者
Lorandeau, Candice G. [1 ]
Hakkinen, Lauren A. [1 ]
Moore, Clara S. [1 ]
机构
[1] Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA
关键词
Down syndrome model; cardiovascular development; prenatal survival; pharyngeal arch arteries; 5TH AORTIC-ARCH; CARDIAC ANOMALIES; FETAL LOSS; CHROMOSOME; PHENOTYPES; FETUSES; HUMAN-CHROMOSOME-21; ABNORMALITIES; MALFORMATIONS; REGION;
D O I
10.1002/ar.21301
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
The Ts65Dn mouse model for Down syndrome (DS) exhibits many phenotypes seen in human DS. Previous research has revealed a reduced rate of transmission of the T65Dn marker chromosome in neonates. To analyze potential fetal loss, litters from trisomic females at 10.5dpc through 14.5dpc were genotyped. No significant differences from the expected Mendelian ratio were found in transmission of T65Dn at any stage. Cardiovascular defects found in trisomic neonates are associated with formation of pharyngeal arch arteries. Vessel tracing was used to identify anomalies in 10.5dpc, 11.5dpc, and 13.5dpc embryos. Comparison of trisomic versus euploid embryos injected with India ink revealed delay and abnormality in cardiovascular development in trisomic embryos at each stage. Through the analysis of transmission rate and cardiovascular development in embryonic mice, we learn more about prenatal mortality and the origins of cardiac abnormality in the Ts65Dn mice to assist in understanding cardiovascular malformation associated with DS. Anat Rec, 294:93-101, 2011. (C) 2010 Wiley-Liss, Inc.
引用
下载
收藏
页码:93 / 101
页数:9
相关论文
共 50 条
  • [1] Embryonic cardiovascular development in the Ts65Dn mouse model for down syndrome
    Hakkinen, Lauren A.
    Moore, Clara S.
    DEVELOPMENTAL BIOLOGY, 2007, 306 (01) : 324 - 324
  • [2] Proteomic analysis of cardiovascular development in the Ts65Dn Down Syndrome mouse model
    Moore, Clara S.
    Kelly, Erik
    Franca, Arianna
    DEVELOPMENTAL BIOLOGY, 2011, 356 (01) : 174 - 175
  • [3] Analysis of cardiovascular anomalies in the Ts65Dn mouse model for Down syndrome
    Williams, Austin D.
    Moore, Clara S.
    DEVELOPMENTAL BIOLOGY, 2007, 306 (01) : 419 - 419
  • [4] Cholinergic Senescence in the Ts65Dn Mouse Model for Down Syndrome
    Kirstein, Martina
    Cambrils, Alba
    Segarra, Ana
    Melero, Ana
    Varea, Emilio
    NEUROCHEMICAL RESEARCH, 2022, 47 (10) : 3076 - 3092
  • [5] Working memory in the Ts65Dn mouse, a model for Down syndrome
    Dowdy-Sanders, NC
    Wenger, GR
    BEHAVIOURAL BRAIN RESEARCH, 2006, 168 (02) : 349 - 352
  • [6] The effect of nicotine in the Ts65Dn, a mouse model for Down syndrome
    Dowdy, NC
    Wenger, GR
    FASEB JOURNAL, 2005, 19 (05): : A1542 - A1542
  • [7] Ts65Dn - Pathologic analysis of a mouse model for Down syndrome
    Davisson, MT
    Schmidt, C
    Bronson, RT
    Costa, ACS
    CYTOGENETICS AND CELL GENETICS, 1999, 86 (01): : 14 - 14
  • [8] Cholinergic Senescence in the Ts65Dn Mouse Model for Down Syndrome
    Martina Kirstein
    Alba Cambrils
    Ana Segarra
    Ana Melero
    Emilio Varea
    Neurochemical Research, 2022, 47 : 3076 - 3092
  • [9] Dysfunctional hippocampal inhibition in the Ts65Dn mouse model of Down syndrome
    Best, Tyler K.
    Cramer, Nathan P.
    Chakrabarti, Lina
    Haydar, Tarik F.
    Galdzicki, Zygmunt
    EXPERIMENTAL NEUROLOGY, 2012, 233 (02) : 749 - 757
  • [10] PCR prescreen for genotyping the Ts65Dn mouse model of Down syndrome
    Lorenzi, Hernan
    Duvall, Nichole
    Cherry, Sheila M.
    Reeves, Roger H.
    Roper, Randall J.
    BIOTECHNIQUES, 2010, 48 (01) : 35 - 37